MDZ: Yale-New Haven Hospital — New Haven, Connecticut

MDZ: Yale-New Haven Hospital is a clinical research site located in New Haven, Connecticut, United States 06504.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MDZ: Yale-New Haven Hospital has participated in 1 clinical trials.

Therapeutic areas: ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MDZ: Yale-New Haven Hospital?

MDZ: Yale-New Haven Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MDZ: Yale-New Haven Hospital conducted?

MDZ: Yale-New Haven Hospital has 1 clinical trials on record. Their work covers ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC.

Is MDZ: Yale-New Haven Hospital accredited by Crixeo Health?

MDZ: Yale-New Haven Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MDZ: Yale-New Haven Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.